Kyphon Takes On Vertebroplasty In Pursuit Of Higher Reimbursement
This article was originally published in The Gray Sheet
Executive Summary
In an effort to stake out higher kyphoplasty reimbursement, Kyphon will begin enrollment by the fourth quarter for a head-to-head trial comparing the spinal treatments vertebroplasty and kyphoplasty
You may also be interested in...
Boston Scientific Loses Share To J&J; Rebate Program Could Buoy Sales
Boston Scientific's share of the U.S. drug-eluting stent market fell four percentage points to 55% during the third quarter as the firm failed to stop Johnson & Johnson/Cordis from stealing market share
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.